Besifloxacin is a fluoroquinolone antibiotic used topically to treat bacterial conjunctivitis. It inhibits bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication. It is grouped under the following drug class(es): Fluoroquinolones, Quinolones and Topoisomerase inhibitors. Its therapeutic use is listed as antibacterials and antibiotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Besivance, 3-Quinolinecarboxylic acid, 7-[(3R)-3-aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-1 and 4-dihydro-4-oxo-. Its PubChem CID is 10178705.
Besifloxacin
| CAS No | 141388-76-3 |
|---|---|
| Molecular Formula | C19H21ClFN3O3 |
| Molecular Weight | 393.84 g/mol |
| Synonyms | 7-[(3R)-3-Aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Besifloxacin is a fluoroquinolone antibiotic used topically to treat bacterial conjunctivitis. It inhibits bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication.
The listed CAS number is 141388-76-3.
The listed molecular formula is C19H21ClFN3O3.
The listed molecular weight is 393.84 g/mol.
7-[(3R)-3-Aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid.
The source lists Besivance, 3-Quinolinecarboxylic acid, 7-[(3R)-3-aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-1 and 4-dihydro-4-oxo-.